Department of Dermatology

Department of Dermatology

Dr. Murphy Research Lab-Publications

  1. Alderson KL, Murphy WJ. 2009. Effects of cancer immunotherapy regimens on primary vs. secondary immune responses and the potential impact on long-term antitumor responses. Adv Exp Med Biol: Crossroads Between Innate and Adaptive Immunity II, ed. 633: 81-89.
  2. Ames E, Hallett WD, Murphy WJ. 2009. Sensitization of human breast cancer cells to natural killer cell-mediated cytotoxicity by proteasome inhibition. Clin Exper Immunol 155: 504-13.
  3. O'Shaughnessy MJ, Vogtenhuber C, Sun K, Sitcheran R, Baldwin AS, Murphy WJ., Dang L, Jaffee B, Palmer E, Serody JS, Blazar BR. 2009. Ex vivo inhibition of NK-kappaB signaling in alloreactive T-cells prevents graft-versus-host disease. Am J Transplant 9: 452-62.
  4. Taylor PA, Ehrhardt MJ, Lees CJ, Panoskaltsis-Mortari A, Krieg AM, Sharpe AH, Murphy WJ., Serody JS, Hemmi H, Akira S, Levy RB, Blazar BR. 2008. TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Blood 112:3508-16.
  5. Sun K, Li M, Sayers TJ, Welniak LA, Murphy WJ.. 2008. Differential effects of donor T cell cytokines on outcome with continuous bortezomib administration following allogeneic bone marrow transplantation. Blood 112: 1522-9.
  6. Shanker A, Brooks AD, Tristan CA, Wine JW, Elliott PJ, Yagita H, Takeda K, Smyth MJ, Murphy WJ, Sayers TJ. 2008. Treating metastatic solid tumors with bortezomib and a tumor necrosis factor-related apoptosis-inducing ligand receptor agonist antibody. J Natl Cancer Inst 100: 649-62.
  7. Redelman D, Welniak LA, Taub D, Murphy WJ. 2008. Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network. Cell Immunol 252: 111-21.
  8. Puliaev R, Puliaeva I, Welniak LA, Ryan AE, Haas M, Murphy WJ, Via CS. 2008. CTL-Promoting Effects of CD40 Stimulation Outweigh B Cell-Stimulatory Effects Resulting in B Cell Elimination and Disease Improvement in a Murine Model of Lupus. J Immunol 181: 47-61.
  9. Murphy WJ. 2008. Raising the specta of T-cell profiling. Blood 112: 3008-9.
  10. Motarjemi M, Hallett WHD, Li M, Murphy WJ. 2008. Proteasome Inhibition: Potential for Sensitization of Immune Effector Mechanisms in Cancer. In Sensitization of Cancer Cells for Chemo/immuno/Radio-therapy., ed. B Bonavida, pp. 51-60. Totowa, NJ: Humana Press
View all publications
The Link above may include papers by scientists with the same or similar names.